Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-defensin 17 Inhibitors

β-defensin 17 inhibitors represent a class of chemical compounds that specifically target and modulate the activity of β-defensin 17, a member of the defensin family of antimicrobial peptides. Defensins are small, cysteine-rich proteins that are known to play significant roles in immune responses by disrupting microbial cell membranes. β-defensin 17, like other members of its class, is characterized by its ability to bind to and destabilize the membranes of bacteria, fungi, and other pathogens through electrostatic interactions facilitated by its cationic nature. Inhibition of β-defensin 17 entails the blocking of its membrane-binding properties, thereby preventing it from exerting its typical functions related to membrane disruption. This process typically involves either small molecules, peptides, or large protein-based inhibitors that can specifically interact with the functional domains of β-defensin 17. The inhibitors often work by binding to the peptide's active sites or through allosteric modulation, which prevents β-defensin 17 from undergoing conformational changes necessary for its activity.

The design of β-defensin 17 inhibitors involves detailed structural and biochemical understanding of the β-defensin 17 protein, its interaction with microbial membranes, and the conformational dynamics that govern its activity. Structural biology tools such as X-ray crystallography, NMR spectroscopy, and molecular docking simulations are employed to elucidate the key interaction sites and to design molecules that can precisely target these areas. Inhibitors often require optimization to ensure high specificity towards β-defensin 17, avoiding off-target effects on other defensins or related peptides. Additionally, β-defensin 17 inhibitors must demonstrate robust binding affinity and stability under physiological conditions, maintaining their ability to disrupt or block the interactions between β-defensin 17 and microbial membranes. These inhibitors can be valuable tools in studying the mechanistic roles of defensins in immune processes and the underlying biochemical pathways they modulate.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits phosphoinositide 3-kinase (PI3K), a kinase involved in the PI3K/Akt pathway. Indirectly influences β-defensin 17 expression by disrupting the signaling cascade that regulates antimicrobial peptides, including β-defensins.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mammalian target of rapamycin (mTOR), a component in the PI3K/Akt pathway. Indirectly modulates β-defensin 17 expression by suppressing mTOR, a kinase crucial for the regulation of antimicrobial peptides, including β-defensins.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 mitogen-activated protein kinase (MAPK), a component in the MAPK signaling pathway. Indirectly disrupts β-defensin 17 expression by suppressing p38 MAPK, a kinase involved in the regulation of antimicrobial peptides, including β-defensins.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits activator protein-1 (AP-1), a transcription factor involved in the regulation of β-defensin 17. By blocking AP-1 activation, this compound directly interferes with the transcriptional control of antimicrobial peptides, including β-defensin 17.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Inhibits Akt, a kinase in the PI3K/Akt pathway. Indirectly influences β-defensin 17 expression by suppressing Akt, a kinase crucial for the regulation of antimicrobial peptides, including β-defensins.

BMS-345541

445430-58-0sc-221741
1 mg
$312.00
1
(1)

Inhibits the IKK complex, directly blocking NF-κB activation. By targeting IKK, it indirectly hinders β-defensin 17 expression, as NF-κB regulates the transcription of antimicrobial peptides, including β-defensins.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$71.00
$202.00
18
(1)

Inhibits glycogen synthase kinase-3 (GSK-3), a kinase involved in the regulation of β-defensin 17. Indirectly modulates β-defensin 17 expression by suppressing GSK-3, a kinase crucial for the regulation of antimicrobial peptides, including β-defensins.

SC514

354812-17-2sc-205504
sc-205504A
5 mg
10 mg
$67.00
$91.00
13
(2)

Inhibits IkB kinase-2 (IKK-2), directly blocking NF-κB activation. By inhibiting IKK-2, it indirectly hinders β-defensin 17 expression, as NF-κB regulates the transcription of antimicrobial peptides, including β-defensins.